Shantha Biotechnics

Shantha Biotechnics Limited is an Indian biotechnology company headquartered in Hyderabad, India.

It is the first Indian company to develop, manufacture and market recombinant human healthcare products in India.

Varaprasad and Ahmed established the company in 1993 to produce affordable drugs for the general population, while maintaining international standards in quality.

In 2006 the European biotech major Mérieux Alliance bought a 60% stake in Shantha Biotechnics at a valuation of $175 million.

[2] In 2009, the vaccine division of French pharmacological company Sanofi Pasteur acquired the stake held by Mérieux Alliance, valuing Shantha Biotech at Euro 550 million (over Rs 3,770 crore).